
Opinion|Videos|July 29, 2024
Identifying Patients Eligible for RSV Vaccine
Experts from clinical and payer backgrounds discuss how patients eligible for the RSV vaccine can be identified.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- How have eligible patients for the RSV vaccine been identified in pharmacies and health systems? Have RSV vaccines become annual immunizations like flu vaccines?
- Have electronic health records been built to identify eligible patients and incorporate RSV vaccines immunization records? How has the identification of eligible patients been implemented into workflow?
- From a payer perspective, how have you ensured eligible patients are identified for immunization?
- From a payer perspective, how have you ensured eligible patients are identified for immunization?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Value-Based Care Interventions and Management of CKD Progression
5